{"id":"https://openalex.org/W2748034841","doi":"https://doi.org/10.4088/jcp.17f11802","title":"Ketamine for Depression, 5: Potential Pharmacokinetic and Pharmacodynamic Drug Interactions","display_name":"Ketamine for Depression, 5: Potential Pharmacokinetic and Pharmacodynamic Drug Interactions","alternate_titles":[],"publication_year":2017,"publication_date":"2017-08-21","ids":{"openalex":"https://openalex.org/W2748034841","doi":"https://doi.org/10.4088/jcp.17f11802","mag":"2748034841","pmid":"https://pubmed.ncbi.nlm.nih.gov/28858450"},"language":"en","primary_location":{"id":"doi:10.4088/jcp.17f11802","doi":"https://doi.org/10.4088/jcp.17f11802","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.17f11802","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2748034841"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033262858","display_name":"Chittaranjan Andrade","orcid":"https://orcid.org/0000-0003-1526-567X","observed_orcids":["https://orcid.org/0000-0003-1526-567X"]},"institutions":[{"id":"https://openalex.org/I699696","display_name":"National Institute of Mental Health and Neurosciences","ror":"https://ror.org/0405n5e57","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I699696"]}],"countries":["IN"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Chittaranjan Andrade","raw_affiliation_strings":["Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India. candrade@psychiatrist.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India. candrade@psychiatrist.com","institution_ids":["https://openalex.org/I699696"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5033262858"],"corresponding_institution_ids":["https://openalex.org/I699696"],"apc_list":null,"apc_paid":null,"fwci":4.494,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.95144704,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"78","issue":"7","first_page":"e858","last_page":"e861"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ketamine","display_name":"ketamine","score":1.0},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.7059999704360962},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.7670000195503235},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9769999980926514},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cyp2b6","display_name":"CYP2B6","score":0.921999990940094},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.9980000257492065},{"id":"https://openalex.org/keywords/genetic-polymorphism","display_name":"genetic polymorphism","score":0.8169999718666077},{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.8759999871253967},{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/glutamatergic-signaling","display_name":"glutamatergic signaling","score":0.9380000233650208},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.6880000233650208},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.9100000262260437},{"id":"https://openalex.org/keywords/off-label-drug-use","display_name":"off-label drug use","score":0.7250000238418579}],"concepts":[{"id":"https://openalex.org/C2780795376","wikidata":"https://www.wikidata.org/wiki/Q243547","display_name":"Ketamine","level":2,"score":0.8613733053207397},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.6645305156707764},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6574426293373108},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.607807993888855},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.6003777980804443},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5923458337783813},{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.5068839192390442},{"id":"https://openalex.org/C50605568","wikidata":"https://www.wikidata.org/wiki/Q14912267","display_name":"CYP2B6","level":5,"score":0.5053640007972717},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4777902066707611},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4607912003993988},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4515100121498108},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.4005982279777527},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.23214539885520935},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.20501163601875305},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.1726461946964264},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13648223876953125},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.11055409908294678},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.09926217794418335},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08567294478416443},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077213","descriptor_name":"Lamotrigine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011110","descriptor_name":"Polymorphism, Genetic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D065702","descriptor_name":"Cytochrome P-450 CYP2B6","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4088/jcp.17f11802","doi":"https://doi.org/10.4088/jcp.17f11802","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.17f11802","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:28858450","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28858450","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.979200005531311,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3175532567","https://openalex.org/W4286382981","https://openalex.org/W4213061543","https://openalex.org/W4405635779","https://openalex.org/W4409281355","https://openalex.org/W2490430720","https://openalex.org/W2135645785","https://openalex.org/W2074581066","https://openalex.org/W2441989698","https://openalex.org/W3082674901"],"abstract_inverted_index":{"Ketamine,":[0],"administered":[1],"in":[2,34,105,117],"subanesthetic":[3],"doses,":[4],"is":[5,169],"gaining":[6],"recognition":[7],"as":[8,154],"an":[9],"off-label":[10],"treatment":[11],"for":[12],"severe":[13],"and":[14,23,73,80,130],"even":[15],"treatment-refractory":[16],"depression.":[17,35],"This":[18],"article":[19],"explores":[20],"potential":[21],"pharmacokinetic":[22],"pharmacodynamic":[24],"drug":[25,46],"interactions":[26,47],"of":[27,32,63,95,114,128,142,148,165],"relevance":[28],"to":[29,49,78,90,108],"the":[30,50,96,106,111,139,162,176,199],"use":[31],"ketamine":[33,40,79,193],"Sparse":[36],"evidence":[37],"suggests":[38,150],"that":[39,52,66,68,81,83,133,151,156,184],"will":[41,75,87],"not":[42,120],"induce":[43,69],"clinically":[44],"significant":[45],"except":[48],"extent":[51],"these":[53,85,172],"are":[54],"predictable":[55],"by":[56],"its":[57],"clinical":[58,112,181],"actions.":[59],"A":[60,124],"small":[61,126,146],"body":[62,147],"literature":[64,149],"indicates":[65],"drugs":[67,82,152,173],"cytochrome":[70],"P450":[71],"(CYP)2B6":[72],"CYP3A4":[74],"reduce":[76,161],"exposure":[77,89,107,118],"inhibit":[84,157],"enzymes":[86],"increase":[88],"ketamine.":[91,109,143],"Common":[92],"genetic":[93],"polymorphisms":[94],"CYP2B6":[97],"gene":[98],"may":[99,137,160],"also":[100,174],"be":[101,190],"associated":[102],"with":[103,192],"variations":[104,116],"However,":[110],"implications":[113],"such":[115],"have":[119],"been":[121],"sufficiently":[122],"studied.":[123],"very":[125],"number":[127],"reports":[129],"studies":[131],"suggest":[132],"concurrent":[134],"benzodiazepine":[135],"medication":[136],"diminish":[138,175],"antidepressant":[140,177],"benefits":[141],"Likewise,":[144],"a":[145],"(such":[153],"lamotrigine)":[155],"glutamatergic":[158],"signaling":[159],"adverse":[163,200],"effects":[164],"ketamine;":[166],"however,":[167],"it":[168],"unknown":[170],"whether":[171],"effect.":[178],"Data":[179],"from":[180],"trials":[182],"indicate":[183],"most":[185],"conventional":[186],"antidepressants":[187],"can":[188],"probably":[189],"combined":[191],"without":[194],"compromising":[195],"efficacy":[196],"or":[197],"increasing":[198],"effect":[201],"burden.\u200b.":[202]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2748034841","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2017-08-31T00:00:00"}
